Vedan International (Holdings) Limited Overview
Vedan International is a Taiwanese-family-controlled, Vietnam-centred fermentation and cassava-processing group. It describes itself as the largest monosodium glutamate (MSG) producer in Southeast Asia and the largest supplier of lysine and cassava-starch-based industrial products in Vietnam. Its integrated complex at Phuoc Thai, Dong Nai, combines molasses- and cassava-based fermentation, starch modification, chlor-alkali (caustic soda/hydrochloric acid) production and cogeneration. This creates a vertically linked value chain from agricultural feedstock to branded "VEDAN" seasoning. The group sold US$374.7m of goods in FY2025: MSG and seasonings were 54%, starch products 17% and a fast-growing PRC coffee-bean trading business 12.5%. Vietnam was 41% of sales, the PRC 20% and Japan 17%. Margins are thin (FY2025 net margin 4.6%), but the balance sheet holds about US$40m of net cash, and the company has moved to a 100% payout policy. The shares trade at roughly 0.4× book value with a double-digit dividend yield.
Company's own description (AR2023 Corporate Profile, repeated in subsequent filings). The group presents itself as Asia's leading producer of fermentation-based amino acids, food additive products and cassava starch-based industrial products. It sells to food distributors, international trading companies and manufacturers of food, paper, textile and chemical products in Vietnam, other ASEAN countries, the PRC, Japan, Taiwan and several European countries. Most products carry the VEDAN brand. The FY2025 results announcement (segment note) describes a single business: manufacturing and selling fermentation-based food additives, biochemical products and cassava-starch-based industrial products, including modified starch, glucose syrup, MSG, glutamic acid (GA) and others.
The H1 2026 interim announcement adds soda to this list and introduces a two-segment presentation (Vietnam and the PRC).
Independent characterisation. Vedan is best understood as three overlapping businesses.
-
Integrated Vietnamese bio-industrial complex. This is the economic core. Molasses and cassava are fermented into glutamic acid, MSG and (historically) lysine. Cassava is processed into native starch, modified starch and starch sugars (glucose syrup, maltose). By-product streams are converted into fertiliser and feed (including CMS, condensed molasses solubles). An on-site chlor-alkali plant produces caustic soda, which neutralises GA into MSG, and hydrochloric acid, which is used in GA production. Surplus chlor-alkali output is sold externally as "specialty chemicals". A cogeneration power system supplies electricity and steam.
-
Consumer and B2B seasoning franchise. In Vietnam, VEDAN-branded MSG, seasonings and soy sauce compete in retail and food-service channels. Vedan Vietnam has been voted a "High-Quality Vietnamese Goods" brand for 19 years (2025 press). Its soy sauce received a "Superior Taste 2026" certification (2026 press). In Japan, a single large customer bought US$36.6m of MSG and GA in FY2025, equal to 9.8% of group revenue.
-
PRC trading and distribution platform. Shanghai and Xiamen began as MSG operations and have evolved largely into distribution of seasonings, bulk food ingredients and especially coffee beans. Coffee bean revenue rose 144.9% to US$46.8m in FY2025 and a further 75.3% year on year to US$34.3m in H1 2026. In H1 2026 the PRC crossed the HKFRS 8 threshold and became a separately reported segment.
Business and revenue model. Revenue comes almost entirely from product sales recognised at a point in time (FY2025 note 2(a): "Sales of goods" US$374.74m). There is no subscription, licensing or service revenue of significance. Small amounts of technical-support income (US$480k in H1 2026), storage income (US$230k in FY2025), rental income and scrap sales appear in "other gains". All contracts last one year or less. Credit terms run from cash on delivery to 30–90 days.
Value-chain position. The group is upstream to midstream. It buys agricultural feedstocks (cassava roots and chips from Vietnam, Thailand and Cambodia; molasses from Vietnam and international markets) and energy (coal, electricity). It then sells intermediate ingredients (MSG, GA, modified starch, glucose syrup, caustic soda, HCl) to industrial users and finished branded seasonings to distributors and retailers.
Customer types. These comprise food distributors and wholesalers; international trading houses (notably Japanese); food processors (instant noodles, snacks, sausages, canned soup, confectionery, bakery); paper and textile mills (modified starch); chemical and water-treatment users (caustic soda, HCl, bleach); agricultural users (fertiliser, feed, CMS in Korea); and coffee roasters and food-service operators in the PRC.
End-markets served. Food seasoning and processing (largest); paper and corrugated board; textiles; animal feed and fertiliser; industrial chemicals; and beverages (coffee).
Financial Narrative
Sources: annual results announcements FY2021–FY2025 (company-reported revenue, gross profit, net profit, EPS, DPS); S&P Global Market Intelligence via StockAnalysis.com (standardised EBIT, EBITDA, balance sheet, cash flow, ratios; last updated September 2026). All figures in US$ millions unless stated.
Income statement
Company-reported operating profit, which includes "other gains – net", was US$22.92m (FY2024) and US$23.10m (FY2025), versus S&P EBIT of US$22.30m and US$22.70m. The difference is mainly FX gains and other items. FY2021 DPS comprises interim 0.272 and final 0.162. FY2022: no interim, no final. FY2023: interim 0.229 and final 0.2298. FY2024: interim 0.273 and final 0.570. FY2025: interim 0.300 and final 0.820.
Revenue CAGR (FY2021–FY2025, four years): −0.5% per year (US$382.4m to US$374.7m). From the FY2022 peak to FY2025, the three-year CAGR is −6.0% per year. Net income CAGR (FY2021–FY2025) is +11.6% per year.
Commentary. The five-year record is a commodity-cost cycle overlaid on a slowly eroding MSG franchise.
FY2022: revenue peaked at US$451.0m (+18.0%) because pass-through pricing on MSG, starch and soda raised top-line sales. Raw material and energy inflation outran pricing, however, so gross margin collapsed 6.2 points to 9.6% and the group made its only loss of the period (−US$4.4m).
FY2023: revenue fell 14.4% as prices normalised and Vietnamese, Japanese and US demand weakened (US −32.5%). Feedstock deflation restored gross margin to 14.4%. Interest expense nearly tripled to US$2.9m as USD rates rose, which capped the recovery.
FY2024–FY2025: revenue drifted down a further 1.6% and 1.4%. Gross margin rose to 17.4–17.7%, a five-year high, on cheaper cassava, molasses and coal. Disciplined starch pricing and the higher-margin specialty-chemical cost base also helped. Net margin reached 4.6%.
The key inflection is that revenue mix is now shifting towards lower-margin traded coffee. This partly explains why H1 2026 gross margin slipped to 17.0% even as revenue grew 11.6%.
Balance sheet
Bank borrowings per company: FY2022 US$59.62m; FY2023 US$43.65m (VND-denominated share 72.6%); FY2024 US$25.32m; FY2025 US$28.04m, all current. At 30 June 2026: US$19.64m. Cash, deposits and wealth-management products at 30 June 2026 totalled US$71.34m, including US$13.82m of FVTPL financial assets first recognised in H1 2026.
Commentary. The balance sheet is conservative and asset-heavy. Equity of US$307m is about 80% of total assets. PP&E has fallen 30% in four years (US$163m to US$115m) because depreciation of about US$21m a year far exceeds capex of US$6–10m. This points to an ageing asset base and harvest-mode capital allocation.
Inventory is the largest current asset (US$137m at FY2025, 37% of total assets). It reflects the deliberate seasonal pre-buying of cassava ("centralised procurement during the production season") and swings working capital by ±US$10–40m a year. Net cash has been rebuilt from −US$15m (FY2022) to +US$40m (FY2025). Debt is entirely short-term working-capital lines, mainly VND-denominated.
Cash flow
Company-reported capex (accrual basis): FY2022 US$13.17m; FY2023 US$8.28m; FY2024 US$6.63m; FY2025 US$9.85m; H1 2026 US$4.27m. The difference from S&P's cash figure reflects timing of payments. TTM to June 2026 (S&P): OCF US$46.9m, capex US$10.0m, FCF US$37.0m, dividends paid US$17.1m.
Commentary. Cash generation is lumpy and driven by inventory. FY2022's negative OCF (−US$24.7m) came almost entirely from a US$38.9m inventory build at inflated prices. FY2024's strong US$48.6m OCF reflected the release of that inventory. Cumulative FY2021–FY2025 FCF of US$62.0m compares with cumulative dividends of US$38.1m. Net debt reduction absorbed the rest. No buyback programme has been used (no repurchases in FY2025 or H1 2026).
Ratios
ROE, ROA, ROIC, current ratio, D/E, net debt/EBITDA and inventory turnover are from S&P. Interest coverage, DSO, DPO and CCC are analyst calculations: DSO and DPO use period-end trade receivables and payables against revenue and COGS; DIO equals 365 divided by S&P inventory turnover. H1 2026 current ratio: 4.28 (company).
Commentary. Returns are structurally low. ROE has not exceeded 6% in five years and is well below a reasonable cost of equity (about 10–12% for a Vietnam/HK small cap). This explains the 0.4× price-to-book. The cash conversion cycle lengthened by about 55 days after FY2022 as the company kept more raw material on hand. This is consistent with its strategy of locking in cassava at harvest-season prices. Leverage is negligible, and interest coverage recovered to above 20× in FY2025.
Interim snapshot: H1 2025 vs H1 2026
Operating profit fell 6.5% despite higher revenue. Selling and distribution expenses rose 24.8% (transportation costs nearly doubled to US$6.2m amid Middle East freight disruption) and repair and maintenance costs rose 28.6%. A lower tax charge (US$2.1m vs US$3.1m, helped by a US$0.9m deferred tax credit) and higher net finance income (US$0.64m vs US$0.12m) lifted net profit.
7. SEGMENTAL AND GEOGRAPHIC REVENUE MAPPING
Geographic revenue by customer location: notes and sources
Sources: AR2023 (FY2022–FY2023), FY2025 announcement (FY2024–FY2025). FY2021 regional split not fully retrieved. Partial FY2021 figure: "Other regions" US$31.52m (FY2021 announcement).
Segment × geography
The company does not publish a product × region matrix. MD&A commentary allows a qualitative mapping:
Fastest-growing and declining regions
PRC: fastest growing: Revenue rose 32.9% in FY2025 and 35.0% in H1 2026, driven by coffee bean distribution. China became the second-largest market in FY2025, overtaking Japan.
United States: volatile growth: Revenue grew 14.4% in FY2025 and 51.0% in H1 2026. Management attributes both increases to customers ordering ahead: of reciprocal tariffs in 2025, and of Middle East-driven price spikes in 2026. It explicitly calls them short-term.
Vietnam: structural decline: Revenue fell from US$195m (FY2022) to US$154m (FY2025), a 21% drop, as low-priced imported MSG took share. H1 2026 showed an 8.5% recovery on volumes.
Japan: secular decline: Revenue fell from US$83m to US$63m between FY2022 and FY2025 on yen weakness (about 155–160 JPY/USD) and weak consumption.
ASEAN and Other: declining: Thai starch oversupply and lower Korean CMS prices caused falls of 17–18% in FY2025.
Asset geography. Non-current assets (excluding deferred tax and prepayments) at FY2025 were Vietnam US$116.6m (93.6%), PRC US$8.0m and Cambodia below US$0.01m.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Income Statement
| Metric (USD Mn) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Revenue | 382.36 | 451.01 | 386.17 | 380.18 | 374.74 |
Cost of sales | 321.99 | 407.66 | 330.74 | 313.94 | 308.27 |
Gross profit | 60.37 | 43.35 | 55.43 | 66.24 | 66.47 |
SG&A (selling plus administrative) | 47.03 | 46.68 | 42.33 | 44.81 | 44.92 |
Operating income (S&P EBIT, excl. other gains) | 14.40 | -2.64 | 14.02 | 22.30 | 22.70 |
EBITDA (S&P) | 32.09 | 15.14 | 35.31 | 44.35 | 43.44 |
Depreciation and amortisation (S&P, for EBITDA) | 17.69 | 17.78 | 21.29 | 22.06 | 20.74 |
Interest expense | 0.34 | 0.95 | 2.88 | 1.54 | 1.01 |
Pre-tax income | 15.01 | -4.20 | 10.35 | 21.53 | 22.92 |
Income tax | 3.98 | 0.19 | 3.35 | 5.46 | 5.84 |
Net income attributable to owners | 11.01 | -4.39 | 6.99 | 16.05 | 17.06 |
Per-share data (US cents)
| Per-share data (US cents) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
EPS basic | 0.72 | -0.29 | 0.46 | 1.05 | 1.12 |
EPS diluted | 0.72 | -0.29 | 0.46 | 1.05 | 1.12 |
Dividends per share declared | 0.434 | 0 | 0.4588 | 0.843 | 1.12 |
Margins (%)
| Margins (%) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Gross margin | 15.79 | 9.61 | 14.35 | 17.42 | 17.74 |
Operating margin (S&P EBIT) | 3.77 | -0.59 | 3.63 | 5.87 | 6.06 |
EBITDA margin | 8.39 | 3.36 | 9.14 | 11.67 | 11.59 |
Net margin | 2.88 | -0.97 | 1.81 | 4.22 | 4.55 |
Effective tax rate | 26.5 | -4.5 | 32.3 | 25.4 | 25.5 |
Balance Sheet and Per-Share Data
| Metric (USD Mn) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Total assets | 389.15 | 405.97 | 383.51 | 368.69 | 385.60 |
Cash and equivalents | 66.14 | 47.81 | 29.68 | 47.47 | 47.03 |
Short-term investments / deposits | 2.53 | 0 | 20.68 | 16.54 | 23.64 |
Cash plus short-term investments | 68.67 | 47.81 | 50.36 | 64.01 | 70.67 |
Inventories | 101.65 | 140.53 | 137.68 | 126.87 | 137.27 |
Trade receivables | 32.16 | 34.12 | 34.53 | 33.90 | 32.93 |
Property, plant and equipment | 163.18 | 157.23 | 142.79 | 127.05 | 114.83 |
Short-term bank debt (incl. current portion of LTD) | 31.67 | 56.19 | 41.66 | 24.66 | 28.03 |
Long-term bank debt | 8.65 | 3.43 | 1.99 | 0.66 | 0 |
Lease liabilities | 3.02 | 3.48 | 3.06 | 3.21 | 2.78 |
Total debt (incl. leases, S&P) | 43.33 | 63.10 | 46.72 | 28.52 | 30.82 |
Net debt (negative = net cash) | -25.34 | 15.29 | -3.64 | -35.49 | -39.85 |
Total equity | 302.02 | 291.72 | 294.78 | 302.42 | 307.07 |
Goodwill and intangibles | 2.10 | 2.08 | 1.53 | 0.97 | 0.92 |
Working capital | 143.78 | 135.51 | 150.29 | 172.96 | 183.79 |
Book value per share (US cents) | 19.8 | 19.2 | 19.3 | 19.8 | 20.2 |
Cash Flow and Margin Analysis (%)
| Metric (USD Mn) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Operating cash flow | 24.87 | -24.71 | 32.18 | 48.62 | 27.68 |
Capital expenditure (cash, S&P) | 11.39 | 11.39 | 8.95 | 5.60 | 9.32 |
Free cash flow | 13.48 | -36.10 | 23.23 | 43.03 | 18.36 |
Dividends paid | 11.19 | 2.47 | 3.49 | 7.67 | 13.25 |
Share buybacks | 0 | 0 | 0 | 0 | 0 |
Change in working capital | -1.01 | -38.51 | 0.29 | 10.69 | -12.37 |
FCF margin (%) | 3.52 | -8.00 | 6.02 | 11.32 | 4.90 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Ratio | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
ROE (%) | 3.66 | -1.48 | 2.39 | 5.38 | 5.61 |
ROA (%) | 2.32 | -0.41 | 2.22 | 3.71 | 3.76 |
ROIC (%) | 3.81 | -0.91 | 3.17 | 5.96 | 6.33 |
Current ratio (x) | 2.98 | 2.28 | 2.83 | 3.82 | 3.46 |
Debt to equity (x) | 0.14 | 0.22 | 0.16 | 0.09 | 0.10 |
Net debt to EBITDA (x) | -0.79 | 1.01 | -0.10 | -0.80 | -0.92 |
Interest coverage, EBIT / interest (x) | 42.4 | -2.8 | 4.9 | 14.5 | 22.5 |
Asset turnover (x) | 0.99 | 1.13 | 0.98 | 1.01 | 0.99 |
Inventory turnover (x) | 3.33 | 3.37 | 2.38 | 2.37 | 2.33 |
Days inventory outstanding | 110 | 108 | 153 | 154 | 157 |
Days sales outstanding | 31 | 28 | 33 | 33 | 32 |
Days payables outstanding | 20 | 25 | 20 | 13 | 20 |
Cash conversion cycle (days) | 121 | 111 | 166 | 174 | 169 |
Income Statement and Margin Analysis (%)
| Metric (USD K) | H1 2025 | H1 2026 |
|---|---|---|
Revenue | 184,267 | 205,590 |
Gross profit | 31,809 | 34,928 |
Operating profit | 11,007 | 10,291 |
Profit before tax | 10,755 | 10,986 |
Profit for the period | 7,610 | 8,900 |
Profit attributable to owners | 7,598 | 8,888 |
Gross margin (%) | 17.3 | 17.0 |
Net margin (%) | 4.1 | 4.3 |
Interim DPS (US cents) | 0.300 | 0.526 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansKey Financials
| Region (USD Mn) | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
Vietnam | 195.00 | 173.56 | 165.96 | 154.32 |
PRC | 62.66 | 54.97 | 56.15 | 74.60 |
Japan | 83.08 | 71.05 | 69.60 | 63.41 |
United States | 36.26 | 24.46 | 29.54 | 33.80 |
ASEAN excluding Vietnam | 35.99 | 31.19 | 31.54 | 26.05 |
Other regions (Taiwan, Korea, EU) | 38.02 | 30.96 | 27.40 | 22.56 |
Total | 451.01 | 386.17 | 380.18 | 374.74 |
Region, % of revenue (%)
| Region, % of revenue (%) | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
Vietnam (%) | 43.2 | 44.9 | 43.7 | 41.2 |
PRC (%) | 13.9 | 14.2 | 14.8 | 19.9 |
Japan (%) | 18.4 | 18.4 | 18.3 | 16.9 |
United States (%) | 8.0 | 6.3 | 7.8 | 9.0 |
ASEAN excl. Vietnam (%) | 8.0 | 8.1 | 8.3 | 7.0 |
Other (%) | 8.5 | 8.1 | 7.2 | 6.0 |
Region, YoY growth (%)
| Region, YoY growth (%) | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
Vietnam | -11.0 | -4.4 | -7.0 |
PRC | -12.3 | 2.1 | 32.9 |
Japan | -14.5 | -2.0 | -8.9 |
United States | -32.5 | 20.8 | 14.4 |
ASEAN excl. Vietnam | -13.4 | 1.1 | -17.4 |
Other | -18.6 | -11.5 | -17.7 |
Key Financials (Half-Yearly)
| Region (USD K) | H1 2025 | H1 2026 |
|---|---|---|
Vietnam | 73,350 | 79,603 |
PRC | 34,851 | 47,051 |
Japan | 32,131 | 31,493 |
United States | 17,573 | 26,540 |
Taiwan | 7,464 | 5,335 |
ASEAN excluding Vietnam | 13,572 | 11,311 |
Other regions | 5,326 | 4,257 |
Total | 184,267 | 205,590 |
Region Overview
| Region | Dominant products | Evidence |
|---|---|---|
Vietnam | MSG/seasonings, starch sugar, fertiliser and feed, all specialty chemicals | Specialty chemicals are "all sold in Vietnam" (FY2025 MD&A) |
PRC | Coffee beans (largest), seasonings, bulk food ingredients | FY2025 and H1 2026 MD&A |
Japan | MSG and GA (single major customer), modified starch | FY2025 note 2(a): US$36.6m single customer |
US | MSG, starch sugar / glucose syrup | H1 2026 MD&A: stockpiling by US customers |
ASEAN | MSG, modified starch | AR2023 MD&A |
Korea | CMS (fertiliser/feed) | FY2025 and H1 2026 MD&A |
Data Point Details
| Data point | Value | Source |
|---|---|---|
Last price | HK$0.68 (16 October 2026) | StockAnalysis (S&P) |
52-week range | About HK$0.56–0.85 (Google Finance, June 2026); HK$0.60–0.85 (August 2026) | Google Finance |
Shares outstanding | 1,522.742m | Company |
Market cap | About HK$1,035m (about US$133m) | Analyst calculation |
Enterprise value | HK$637m (14 October 2026) | S&P |
Price at fiscal year-end (HK$, S&P "last close") | FY2021 | FY2022 |
Share price (HKD) | 0.48 | 0.38 |
Market cap (HKD Mn) | 1,081 | 838 |
Valuation Multiples
| Multiple | Vedan, current (S&P, Oct 2026) | Vedan FY2025 | Fufeng (0546.HK) |
|---|---|---|---|
P/E (x) | 7.07 | 7.69 | About 6.65 (Google Finance, Feb 2026 snapshot) |
EV/EBITDA (x) | 1.85 | 2.31 | — |
EV/Sales (x) | 0.20 | 0.27 | — |
P/B (x) | 0.42 | 0.43 | About 1.13 (Google Finance) |
Dividend yield (%) | 13.1 (S&P) / 15.4 (analyst, declared TTM) | 14.9 | About 4.75 (Google Finance, Feb 2026) |
Dividend (US cents per share)
| Dividend (US cents per share) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Interim | 0.272 | 0 | 0.229 | 0.273 | 0.300 |
Final | 0.162 | 0 | 0.2298 | 0.570 | 0.820 |
Total | 0.434 | 0 | 0.4588 | 0.843 | 1.120 |
Payout ratio (%) | 60 | 0 | 100 | 80 | 100 |
Debt maturity profile (USD Mn)
| Debt maturity profile (USD Mn) | Within 1 year | 1–2 years | 2–5 years | Over 5 years |
|---|---|---|---|---|
Bank borrowings, 31 Dec 2025 | 28.04 | 0 | 0 | 0 |
Bank borrowings, 30 Jun 2026 | 19.64 | 0 | 0 | 0 |
Lease liabilities, 30 Jun 2026 (current vs non-current) | 0.42 | 2.25 | 0 | 0 |
Catalyst / Monitorable Details
| Catalyst / monitorable | Timing | What to watch |
|---|---|---|
FY2026 annual results and final dividend | March 2027 | Whether H2 holds after US pull-forward; full-year payout ratio |
Cassava procurement for the 2026/27 season | Q4 2026 – Q1 2027 | Prices locked in; starch gross margin |
Middle East energy and freight normalisation | Ongoing | Transport costs (US$6.2m in H1 2026) and coal prices |
PRC segment profitability | FY2026 report | Segment margin trend (5.3% in H1 2026) as coffee scales |
Vietnam MSG pricing vs imports | Ongoing | Vietnam revenue and share commentary |
Japanese anchor customer | FY2026 report | Revenue from the single customer (US$36.6m in FY2025) |
Annual Report 2025 disclosures | Published April 2026 | Director pay, ESG metrics, associate identity |
HKFRS 18 adoption | From 1 January 2027 | Restated operating-profit presentation |
Corporate actions | Any time | Buyback, privatisation, M&A from the "strategic M&A" agenda |
Environmental compliance | Ongoing | Any Vietnamese regulatory action at Dong Nai |
Executive Leadership
Board of Directors
| Name | Title | Director since | Age (AR2023) | Background / education |
|---|---|---|---|---|
YANG Tou-Hsiung (楊頭雄) | Chairman, Executive Director; Chair, Nomination Committee | 2002 | 81 | Co-founder of Taiwan Vedan Group. About 61 years in MSG. Graduate of Taichung Min Der Commercial Vocational High School. Director of Vedan Vietnam, Taiwan Vedan, Billion Power Ltd, King International Ltd. Executive director, Taiwan Amino Acid Manufacturers Association |
YANG Cheng (楊正) | Executive Director (business development strategy) | 2002 | 69 | About 48 years in MSG. EMBA, Xiamen University (2004). Chairman of Wanpao Asset Management; President of Fongle Real Estate. Director of Taiwan Vedan, Billion Power, King International |
YANG Kun-Hsiang (楊坤祥) | Executive Director and Chief Executive Officer | 2002 | 66 | MSc Agricultural Chemistry, Meiji University (Japan). With Vedan Vietnam since 1991; Vice Chairman of Vedan Vietnam. Director of Taiwan Vedan, Billion Power, Concord Worldwide Holdings |
YANG Chen-Wen (楊辰文) | Executive Director (purchasing coordination) | 2002 | 60 | BSc Mechanics, Waseda University (1993). Chairman of Shanghai Vedan and Xiamen Vedan. Director of High Capital Investments Ltd |
YANG Kun-Chou (楊坤洲) | Executive Director | 2012 | 64 | About 42 years in food, beverage and consumer products. Former director of Ve Wong Corporation (TWSE). Director of Vedan Vietnam, Shanghai Vedan, Xiamen Vedan, Concord Worldwide |
HUANG Ching-Jung (黃景榮) | Non-executive Director; Remuneration Committee member | 2002 | 70 | Accounting and statistics graduate, National Taichung Commercial College (1974). Chairman of Champion Marketing Co. (Taiwan Vedan affiliate) |
CHOU Szu-Cheng (周賜程) | Non-executive Director | 2006 | 63 | LLB Soochow; LLM East China University of Political Science and Law; PhD Law, Peking University. Supervisor of Taiwan Vedan. INED of Shih-Kuen Plastics |
CHAO Pei-Hong (趙培宏) | INED; Chair, Audit Committee | 2002 | 62 | LLB/LLM Soochow; LLM University of Houston. Executive partner, Jurist Law Offices (Taiwan) |
KO Jim-Chen (柯俊禎) | INED; Chair, Remuneration Committee | 2004 | 63 | BBA Feng Chia; MSc Accounting, University of Delaware. Executive partner, Weyong International CPAs |
HUANG Chung-Fong (黃鐘鋒) | INED; Audit Committee member | 2018 | 68 | BSc/MSc National Chiao Tung University. Former president of Acer Taiwan Regional Operations and Weblink International |
LEE Peir-Fen (Ms) | INED | — | — | — |
Executive Leadership Team
| Name | Role | Age (AR2023) | Background |
|---|---|---|---|
NI Chih-Hao | Group CFO; President of Vedan Vietnam | 58 | University of Oregon; MBA Tunghai. Joined 1993 |
CHAO Wen-Jui | General Plant Manager, Vedan Vietnam | 60 | MSc Chemistry, National Tsing Hua. Joined Taiwan Vedan 1987 |
YANG Tzu-Chang | VP Specialty Chemicals, Vedan Vietnam | 62 | Economics, NTU. Joined 1991 |
KO Chung-Chih | VP, Vedan Vietnam (management systems and administration) | 61 | Master of Management, National University of Kaohsiung |
YANG Tung | General Manager, Shanghai Vedan | 54 | Ling Tung University. Joined 1994 |
YANG Meng-Ta | VP, Taiwan Branch | 50 | BSc NTU; MSc Civil Engineering, Penn State. Joined 2001 |
Directors' Remuneration
| Attribute | Status |
|---|---|
Board size | 11 (5 executive, 2 non-executive, 4 INED) |
Independence | 36% INEDs (4/11), above the one-third requirement. Non-executive share (NED plus INED) 55% |
Chair / CEO separation | Yes. Chairman Yang Tou-Hsiung; CEO Yang Kun-Hsiang (cousins) |
Gender | 1 female director (Lee Peir-Fen) since 2025 = 9%. In 2023: 0% board, 27% senior management, 20% other staff |
Audit Committee | All four INEDs; chair Chao Pei-Hong. Two meetings in FY2023 |
Remuneration Committee | Ko Jim-Chen (chair), Chao Pei-Hong, Huang Ching-Jung (NED), plus formerly Chen Joen-Ray |
Nomination Committee | Yang Tou-Hsiung (chair), Chao Pei-Hong, Ko Jim-Chen, plus formerly Chen Joen-Ray |
Investment Review Board | Management-level committee evaluating medium- to long-term investments and alliances |
CG Code deviation | Chairman did not attend the AGMs of 23 May 2023, 27 May 2025 and 26 May 2026 (code provision F.1.3 / F.2.2) |
INED tenure | Chao (24 years) and Ko (22 years) serve well beyond nine years. This is a governance weakness under HKEX tenure guidance |
Board & Management Changes
| Date | Change |
|---|---|
31 Mar 2025 | INED Chen Joen-Ray (since 2008) ceased to be a director (MarketScreener) |
| 2025 | Ms Lee Peir-Fen appointed INED. This met the AR2023 commitment to appoint at least one female director by 31 December 2024 slightly late |
No change | C-suite unchanged since at least 2012 |
Major Shareholders
| Holder | Shares | % of issued |
|---|---|---|
Taiwan Vedan (Vedan Enterprise Corp. and affiliates) | 512,082,512 | 33.62 |
Yang Tou-Hsiung (personal and controlled corporations, e.g. King International / Billion Power) | 169,730,196 | 11.15 |
Concord Worldwide Holdings Ltd (Yang Kun-Hsiang / Kun-Chou-linked) | 127,297,646 | 8.36 |
High Capital Investments Ltd (Yang Chen-Wen / Yang Tung-linked) | 127,297,646 | 8.36 |
Unnamed holder (name not captured in source) | 83,348,000 | 5.47 |
Targets & Commitments
| Initiative | Date | Detail | Status |
|---|---|---|---|
Mitsui & Co. bio-stimulant JV | Dec 2024 | New Vietnamese company for international trade of bio-stimulant products | Established. Financial impact ND |
Coffee bean supply-chain build-out (PRC) | FY2024–2026 | Integrated sourcing-to-warehouse model; revenue up from US$19m (FY2024) to US$47m (FY2025) | Scaling. 16.7% of H1 2026 revenue |
Increased associate investment | FY2025 | Associate carrying value rose from US$4.1m to US$8.6m (implying about US$5m of new capital). Investee name ND | Completed |
Third-party brand distribution in Vietnam | 2023–2026 | Agreements with international consumer brands | Ongoing; revenue declining |
Treasury diversification | H1 2026 | US$13.8m placed in FVTPL wealth-management products | New |
Shift to VND borrowings | 2023–2026 | Borrowing mix shifted to VND and total borrowings reduced 30% in H1 2026 | Ongoing |
Dividend payout increase | FY2023–FY2026 | 100% payout (FY2023, FY2025); 90% (H1 2026) | Policy in practice; no formal written policy disclosed |
ESG recognition | 2025–2026 | Vedan Vietnam certified "National Green ESG Enterprise 2025"; Asia Responsible Enterprise Award 2026 | Achieved |
Competitive Landscape
Key Competitors
| Competitor | Listing | Overlap with Vedan | Comparative scale | Relative positioning |
|---|---|---|---|---|
Fufeng Group | HKEX 0546 | MSG, starch sweeteners, amino acids, fertiliser | FY2025 revenue RMB27.88bn (+0.4%); attributable profit RMB2.47bn; GM 19.7% | Self-described world-largest MSG producer; corn-based PRC scale cost leader |
Meihua Holdings Group | SSE 600873 | MSG, lysine, threonine, food amino acids | FY2025 revenue RMB24.21bn (−3.4%); net profit RMB3.28bn (+19.7%); H1 2026 profit −62.6% | Acquired Kyowa Hakko's food and pharma amino acids (July 2025); global footprint including Thailand |
Ajinomoto Co. (incl. Ajinomoto Vietnam) | TSE 2802 | MSG and seasonings in Vietnam, ASEAN, Japan; amino acids | — | Global brand leader; Vedan's main branded rival in Vietnam |
Daesang Corp. (Miwon brand) | KRX | MSG and seasonings in Vietnam and Indonesia | — | Korean seasoning major with a Vietnamese presence |
CJ CheilJedang (Bio division) | KRX | Amino acids (lysine), seasonings | — | Global feed amino acid leader |
PT Sasa Inti / Indonesian MSG producers | Private | ASEAN MSG | — | Regional price competitors |
Chinese MSG exporters (Linghua, Eppen, others) | Various | Low-priced MSG imports into Vietnam and ASEAN | — | Named by Vedan (as "imported alternatives") as the cause of its FY2025 Vietnam share loss |
Thai cassava starch producers (e.g., Thai Wah, SMS Corporation) | SET / private | Native and modified starch | — | Thai overcapacity depressed prices in FY2025 |
China Starch Holdings | HKEX 3838 | Starch, starch sugars (corn-based) | Market cap about HK$1.0–1.2bn (TipRanks/Paasa) | PRC corn starch peer |
Global Bio-chem Technology | HKEX 0809 | Corn-based amino acids and sweeteners | Market cap about HK$0.9bn (TipRanks) | Distressed PRC peer |
Vietnamese chlor-alkali producers (e.g., Viet Tri Chemical, Southern Basic Chemicals) | HOSE / UPCoM | Caustic soda, HCl | — | Low-price HCl competition cited by Vedan |
PRC coffee importers and traders | Various | Coffee bean distribution | — | Fragmented market; low entry barriers |
Peer Comparison FY2025
| Metric | Vedan (2317.HK) | Fufeng (0546.HK) | Meihua (600873.SS) |
|---|---|---|---|
FY2025 revenue (approx. USD Mn) | 375 | 3,927 | 3,410 |
Revenue growth FY2025 (%) | -1.4 | 0.4 | -3.4 |
Gross margin (%) | 17.7 | 19.7 | about 22 (TTM Sep 2025, Simply Wall St) |
Net margin (%) | 4.6 | 8.9 | 13.6 |
Dividend payout FY2025 (%) | 100 | 44.8 | 42.8 |
Recent Developments
Litigation, regulatory actions, layoffs: * "Restructure the organisation and optimise manpower" was added to the H1 2026 action plan, but no numbers were given.
